Reply to Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”

키워드

참고문헌 (13)

1. Yuanbin Liu, "Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”", Clinical and Molecular Hepatology, 29(1), pp.163~164 (2023), 대한간학회
2. Hwi Young Kim, "Recent advances in nonalcoholic fatty liver disease metabolomics", Clinical and Molecular Hepatology, 27(4), pp.553~559 (2021), 대한간학회[DOI]
3. Nam HH, "Osthol attenuates hepatic steatosis via decreased triglyceride synthesis not by insulin resistance", World J Gastroenterology, 20, pp.11753~11761 (2014)
4. 강성희, "KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 27(3), pp.363~401 (2021), 대한간학회
5. Yi-Wen Ting, "Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort", Clinical and Molecular Hepatology, 27(3), pp.486~498 (2021), 대한간학회[DOI]
6. Kenichi Ikejima, "Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights", Clinical and Molecular Hepatology, 26(4), pp.728~735 (2020), 대한간학회
7. Gwyneth Soon, "Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective", Clinical and Molecular Hepatology, 27(1), pp.44~57 (2021), 대한간학회[DOI]
8. Kyung-Soo Kim, "Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 26(4), pp.430~443 (2020), 대한간학회[DOI]
9. Wang S, "An overview of ferroptosis in non-alcoholic fatty liver disease", Biomed Pharmacother, 153, pp.113374~ (2022)
10. Chen J, "The multifaceted role of ferroptosis in liver disease", Cell Death Differ, 29, pp.467~480 (2022)
11. Rahul Kumar, "Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma", Clinical and Molecular Hepatology, 26(2), pp.196~208 (2020), 대한간학회[DOI]
12. Kim HY, "Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome", Commun Biol, 4, pp.824~ (2021)
13. Yang L, "Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms", Signal Transduct Target Ther, 5, pp.138~ (2020)

관련 논문AI추천